Breaking News

BD to Invest $110M to Expand Production of Prefillable Syringes

Will bring BD Neopak Glass Prefillable Syringe production to Columbus, Nebraska.

Author Image

By: Charlie Sternberg

Associate Editor

BD, a global medical technology company, is investing $110 million to expand its production of prefillable syringes, helping accelerate biologic and GLP-1 drug delivery and supporting pharmaceutical reshoring in the U.S. This investment will bring BD Neopak Glass Prefillable Syringe production to Columbus, Nebraska, creating approximately 120 new jobs and reinforcing the company’s supply resilience within its Pharmaceutical Systems portfolio. Supply is expected to begin in mid-2026. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters